Authors:
CARTY TJ
SWEENEY FJ
GRIFFITHS RJ
ESKRA JD
ERNEST MJ
PILLAR JS
CHENG JD
LOOSE LD
JOSEPH PA
PAZOLES PP
MOORE PF
NAGAHISA A
MURASE S
KADIN SB
Citation: Tj. Carty et al., TENIDAP INHIBITS 5-LIPOXYGENASE PRODUCT FORMATION IN-VITRO, BUT THIS ACTIVITY IS NOT OBSERVED IN 3 ANIMAL-MODELS, Inflammation research, 46(5), 1997, pp. 168-179
Authors:
MOORE PF
LARSON DL
OTTERNESS IG
WEISSMAN A
KADIN SB
SWEENEY FJ
ESKRA JD
NAGAHISA A
SAKAKIBARA M
CARTY TJ
Citation: Pf. Moore et al., TENIDAP, A STRUCTURALLY NOVEL DRUG FOR THE TREATMENT OF ARTHRITIS - ANTIINFLAMMATORY AND ANALGESIC PROPERTIES, Inflammation research, 45(2), 1996, pp. 54-61
Authors:
ANDREWS EG
ANTOGNOLI GW
BRESLOW R
CARTA MP
CARTY TJ
CHAMBERS RJ
CHENG JB
COHAN VL
COLLINS JL
DAMON DB
DELEHUNT J
EGGLER JF
ESKRA JD
FREIERT KW
HADA WA
MARFAT A
MASAMUNE H
MELVIN LS
MULARSKI CJ
NACLERIO BA
PAZOLES CJ
PILLAR JS
RAPPACH LA
REICHE P
RUSEK FW
SHERMAN H
SHIRLEY JT
SWEENEY FJ
TICKNER JE
WATSON JW
WRIGHT CF
Citation: Eg. Andrews et al., SYNTHESIS AND PHARMACOLOGICAL PROFILE OF 2 NOVEL HETEROCYCLIC CHROMANOLS, CP-80,798 AND CP-85,958, AS POTENT LTD(4) RECEPTOR ANTAGONISTS, Bioorganic & medicinal chemistry letters, 5(13), 1995, pp. 1365-1370